中重度缺氧缺血性脑病新生儿全身亚低温治疗、脑磁共振生物标志物与结局:三级中心出生与其他机构出生的巢式研究
该巢式队列研究嵌套于一项随机临床试验,纳入印度、斯里兰卡和孟加拉国7个三级新生儿重症监护病房的408名胎龄≥36周、中重度缺氧缺血性脑病新生儿,随机接受全身亚低温(直肠温度降至33.0–34.0°C,持续72小时)或无亚低温(直肠温度维持36.0–37.0°C),出生后6小时内开始。亚低温组与对照组在三级中心出生儿(丘脑NAA OR -0.28,95%CI -1.62至1.07,P=0.68)和其他机构出生儿(OR 0.05,95%CI -0.62至0.71,P=0.89)的丘脑NAA均无差异,乳酸/NAA比值、脑损伤评分及白质各向异性亦无差异。死亡或残疾在三级中心出生儿(58.6% vs 56.7%;RR 1.03,95%CI 0.76–1.41)和其他机构出生儿(46.7% vs 43.2%;RR 1.08,95%CI 0.83–1.41)均无显著降低。结论提示在低收入和中等收入国家,全身亚低温未与脑损伤减少相关,不支持使用。
要点
- 在低收入和中等收入国家,无论三级中心出生还是其他机构出生,全身亚低温均未降低中重度缺氧缺血性脑病新生儿的死亡或残疾风险(三级中心出生RR 1.03,95%CI 0.76–1.41;其他机构出生RR 1.08,95%CI 0.83–1.41)。
- 亚低温组与对照组在三级中心出生儿和其他机构出生儿的丘脑NAA、乳酸/NAA比值、脑损伤评分及白质各向异性均无差异(P值均>0.05)。
- 三级中心出生儿在出生时更可能需要插管(78.9% vs 29.1%,P=0.001),但重度缺氧缺血性脑病比例与其他机构出生儿无差异(23.6% vs 17.9%,P=0.22)。
- 作者认为,这些发现不支持在低收入和中等收入国家的新生儿缺氧缺血性脑病中使用全身亚低温。
适用人群与场景
- 纳入胎龄≥36周、中重度缺氧缺血性脑病的新生儿,来自印度、斯里兰卡和孟加拉国的7个三级新生儿重症监护病房,2015年8月15日至2019年2月15日纳入。
- 按出生地点分为三级中心出生(inborn)和其他机构出生(outborn),共408名,其中三级中心出生123名、其他机构出生285名。
诊断标准与关键阈值
- 中重度缺氧缺血性脑病的诊断标准未在本文中详述。
- 干预条件:出生后6小时内开始全身亚低温,直肠温度降至33.0°C至34.0°C,持续72小时;对照组直肠温度维持36.0°C至37.0°C。
研究设计与关键结果
- 研究类型:随机临床试验的巢式队列研究,共408名新生儿,来自7个三级新生儿重症监护病房;三级中心出生123名,其他机构出生285名;平均(SD)胎龄38.7(1.3)周;267名(65.4%)为男性。
- 三级中心出生儿与其他机构出生儿相比:体重更小(平均[SD] 2.8[0.5] kg vs 2.9[0.4] kg;P=0.02),器械分娩或剖宫产比例更高(43.1% vs 24.7%;P=0.01),出生时插管比例更高(78.9% vs 29.1%;P=0.001),但重度缺氧缺血性脑病比例无差异(23.6% vs 17.9%;P=0.22)。
- 共267名新生儿(三级中心出生80名,其他机构出生187名)有磁共振数据纳入分析。
- 亚低温组 vs 对照组:三级中心出生儿丘脑NAA平均水平(SD)为8.04(1.98) vs 8.31(1.13)(OR -0.28;95%CI -1.62至1.07;P=0.68);其他机构出生儿为8.03(1.89) vs 7.99(1.72)(OR 0.05;95%CI -0.62至0.71;P=0.89)。
- 亚低温组 vs 对照组:三级中心出生儿丘脑乳酸/NAA峰面积比值中位数(IQR)为0.13(0.10–0.20) vs 0.12(0.09–0.18)(OR 1.02;95%CI 0.96–1.08;P=0.59);其他机构出生儿为0.14(0.11–0.20) vs 0.14(0.10–0.17)(OR 1.03;95%CI 0.98–1.09;P=0.18)。
- 亚低温组与对照组在三级中心出生儿或其他机构出生儿中的脑损伤评分及白质各向异性均无差异。
- 死亡或残疾:三级中心出生儿亚低温组 vs 对照组为34名(58.6%) vs 34名(56.7%),风险比1.03(95%CI 0.76–1.41);其他机构出生儿为64名(46.7%) vs 60名(43.2%),风险比1.08(95%CI 0.83–1.41)。
证据类型、等级与局限
- 证据类型:随机临床试验的巢式队列研究。
对床旁实践的改变
- 作者认为,这些发现不支持在低收入和中等收入国家的新生儿缺氧缺血性脑病中使用全身亚低温。
指南或共识出处
- 临床试验注册号:NCT02387385。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: The association between place of birth and hypothermic neuroprotection after hypoxic-ischemic encephalopathy (HIE) in low- and middle-income countries (LMICs) is unknown.
OBJECTIVE: To ascertain the association between place of birth and the efficacy of whole-body hypothermia for protection against brain injury measured by magnetic resonance (MR) biomarkers among neonates born at a tertiary care center (inborn) or other facilities (outborn).
DESIGN, SETTING, AND PARTICIPANTS: This nested cohort study within a randomized clinical trial involved neonates at 7 tertiary neonatal intensive care units in India, Sri Lanka, and Bangladesh between August 15, 2015, and February 15, 2019. A total of 408 neonates born at or after 36 weeks' gestation with moderate or severe HIE were randomized to receive whole-body hypothermia (reduction of rectal temperatures to between 33.0 °C and 34.0 °C; hypothermia group) for 72 hours or no whole-body hypothermia (rectal temperatures maintained between 36.0 °C and 37.0 °C; control group) within 6 hours of birth, with follow-up until September 27, 2020.
EXPOSURE: 3T MR imaging, MR spectroscopy, and diffusion tensor imaging.
MAIN OUTCOMES AND MEASURES: Thalamic N-acetyl aspartate (NAA) mmol/kg wet weight, thalamic lactate to NAA peak area ratios, brain injury scores, and white matter fractional anisotropy at 1 to 2 weeks and death or moderate or severe disability at 18 to 22 months.
RESULTS: Among 408 neonates, the mean (SD) gestational age was 38.7 (1.3) weeks; 267 (65.4%) were male. A total of 123 neonates were inborn and 285 were outborn. Inborn neonates were smaller (mean [SD], 2.8 [0.5] kg vs 2.9 [0.4] kg; P = .02), more likely to have instrumental or cesarean deliveries (43.1% vs 24.7%; P = .01), and more likely to be intubated at birth (78.9% vs 29.1%; P = .001) than outborn neonates, although the rate of severe HIE was not different (23.6% vs 17.9%; P = .22). Magnetic resonance data from 267 neonates (80 inborn and 187 outborn) were analyzed. In the hypothermia vs control groups, the mean (SD) thalamic NAA levels were 8.04 (1.98) vs 8.31 (1.13) among inborn neonates (odds ratio [OR], -0.28; 95% CI, -1.62 to 1.07; P = .68) and 8.03 (1.89) vs 7.99 (1.72) among outborn neonates (OR, 0.05; 95% CI, -0.62 to 0.71; P = .89); the median (IQR) thalamic lactate to NAA peak area ratios were 0.13 (0.10-0.20) vs 0.12 (0.09-0.18) among inborn neonates (OR, 1.02; 95% CI, 0.96-1.08; P = .59) and 0.14 (0.11-0.20) vs 0.14 (0.10-0.17) among outborn neonates (OR, 1.03; 95% CI, 0.98-1.09; P = .18). There was no difference in brain injury scores or white matter fractional anisotropy between the hypothermia and control groups among inborn or outborn neonates. Whole-body hypothermia was not associated with reductions in death or disability, either among 123 inborn neonates (hypothermia vs control group: 34 neonates [58.6%] vs 34 [56.7%]; risk ratio, 1.03; 95% CI, 0.76-1.41), or 285 outborn neonates (hypothermia vs control group: 64 neonates [46.7%] vs 60 [43.2%]; risk ratio, 1.08; 95% CI, 0.83-1.41).
CONCLUSIONS AND RELEVANCE: In this nested cohort study, whole-body hypothermia was not associated with reductions in brain injury after HIE among neonates in South Asia, irrespective of place of birth. These findings do not support the use of whole-body hypothermia for HIE among neonates in LMICs.
TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02387385.
参考来源
- Thayyil S, Montaldo P, Krishnan V, et al. Whole-Body Hypothermia, Cerebral Magnetic Resonance Biomarkers, and Outcomes in Neonates With Moderate or Severe Hypoxic-Ischemic Encephalopathy Born at Tertiary Care Centers vs Other Facilities: A Nested Study Within a Randomized Clinical Trial. JAMA Netw Open. 2023. PMID: 37155168. doi:10.1001/jamanetworkopen.2023.12152
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。